Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/7950
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMajmudar, Nishita D.-
dc.date.accessioned2018-10-05T06:00:19Z-
dc.date.available2018-10-05T06:00:19Z-
dc.date.issued2018-05-
dc.identifier.otherPDR00513-
dc.identifier.urihttp://10.1.7.192:80/jspui/handle/123456789/7950-
dc.language.isoenen_US
dc.publisherInstitute of Pharmacy, Nirma University, A'baden_US
dc.relation.ispartofseriesPDR00513;PDR00513-
dc.subjectPDR00513en_US
dc.subjectPharmaceutical Analysisen_US
dc.subjectDissertation Reporten_US
dc.titleEvolution of Anda Submission and Impact of Current Guidance of Approval Processen_US
dc.typeDissertationen_US
Appears in Collections:Poster Presentations

Files in This Item:
File Description SizeFormat 
PDR00513.pdf26.68 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.